InvestorsHub Logo
Followers 3
Posts 219
Boards Moderated 0
Alias Born 11/06/2016

Re: None

Saturday, 11/24/2018 2:38:46 PM

Saturday, November 24, 2018 2:38:46 PM

Post# of 3057
ChromaDex's best-case scenario would be if the PTAB upholds the patents in January, and if the SDNY dismisses most of Elysium's claims in January based on Noerr-Pennington immunity. That scenario is highly plausible, although of course not a sure thing. But if it occurs, then Elysium will be mostly playing defense.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News